Research Article
Prognostic Significance of Percutaneous Coronary Intervention for First Acute Myocardial Infarction with Heart Failure: Five-Year Follow-Up Results
Table 4
Univariate and multivariate logistic regression analyses.
| Variables | Univariate logistic regression | Multivariate logistic regression | OR | 95% CI | P | OR | 95% CI | P |
| Age | 1.063 | 1.014–1.087 | ≤0.001 | 1.008 | 1.054–1.123 | ≤0.001 | Systolic pressure | 0.998 | 0.975–1.001 | 0.640 | | | | Peak troponin I | 1.002 | 1.016–1.028 | ≤0.001 | 1.020 | 1.006–1.034 | 0.004 | Peak CK-MB | 1.004 | 1.003–1.006 | ≤0.001 | 1.000 | 0.995–1.004 | 0.831 | White blood cell count | 1.128 | 1.056–1.206 | ≤0.001 | 0.921 | 0.614–1.384 | 0.693 | Platelet count | 1.005 | 1.002–1.009 | 0.202 | | | | Neutrophil count | 1.147 | 1.073–1.227 | ≤0.001 | 1.055 | 0.693–1.606 | 0.801 | Hs-CRP | 1.032 | 1.015–1.049 | ≤0.001 | 1.002 | 0.997–1.047 | 0.091 | Creatinine | 0.993 | 0.981–1.005 | 0.245 | | | | ALT | 1.012 | 1.006–1.018 | 0.060 | | | | AST | 1.004 | 1.002–1.005 | 0.001 | 0.997 | 0.993–1.000 | 0.073 | Total bilirubin | 1.038 | 1.005–1.072 | 0.022 | 0.987 | 0.926–1.051 | 0.679 | Fasting plasma glucose | 1.018 | 1.030–1.135 | 0.002 | 0.908 | 0.862–0.956 | 0.363 | Hematocrit | 0.069 | 1.000–1.008 | 0.069 | | | | BNP | 1.001 | 1.000–1.001 | 0.073 | | | | LVEF | 0.872 | 0.847–0.899 | ≤0.001 | 0.908 | 0.862–0.956 | ≤0.001 | LVEDD | 1.174 | 1.121–1.231 | ≤0.001 | 1.136 | 1.016–1.271 | 0.025 | LVESD | 1.117 | 1.128–1.227 | ≤0.001 | 0.987 | 0.880–1.107 | 0.828 | STEMI | 2.983 | 1.583–5.623 | 0.001 | 0.772 | 0.319–1.886 | 0.565 | Preinfarction angina | 0.637 | 0.408–0.995 | 0.048 | 0.554 | 0.299–1.027 | 0.061 | LAD (PCI) | 1.995 | 1.252–3.180 | 0.004 | 0.888 | 0.164–4.818 | 0.891 | RCA (PCI) | 0.512 | 0.312–0.841 | 0.008 | 3.248 | 0.792–13.328 | 0.102 | LAD (culprit) | 2.042 | 1.293–3.225 | 0.002 | 1.232 | 0.222–6.827 | 0.811 | RCA (culprit) | 0.495 | 0.295–0.831 | 0.008 | 0.249 | 0.051–1.224 | 0.087 | Single-vessel disease | 1.586 | 1.020–2.465 | 0.040 | 2.037 | 1.067–3.888 | 0.031 | TIMI-0 (before) | 2.973 | 1.850–4.777 | ≤0.001 | 2.012 | 0.219–18.462 | 0.536 | TIMI-3 (before) | 0.334 | 0.206–0.541 | ≤0.001 | 0.993 | 0.100–8.688 | 0.952 | IIb/IIIa inhibitor | 1.777 | 1.124–2.809 | 0.014 | 1.192 | 0.616–2.305 | 0.603 | β-Blocker | 2.489 | 0.973–6.364 | 0.057 | | | | Spironolactone | 4.550 | 2.000–10.353 | ≤0.001 | 1.123 | 0.349–3.612 | 0.846 |
|
|
Hs-CRP: hypersensitive C-reactive protein; AST: aspartate aminotransferase; ALT: alanine aminotransferase; HDL-C: high-density lipoprotein cholesterol; BNP: B-type natriuretic peptide; LVEF: left ventricular ejection fraction; LVEDD: left ventricular end-diastolic diameter; LVESD: left ventricular end-systolic diameter; STEMI: ST-segment elevation myocardial infarction; LAD: left anterior descending artery; LCX: left circumflex artery; RCA: right coronary artery.
|